Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengjiao Dunbar

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
BMC Bioinformatics|May 18, 2021
Estimating colocalization probability from limited summary statisticsEmily A King, Fengjiao Dunbar, Justin Wade Davis, et al.
Genes|September 20, 2019
Detection of Differentially Methylated Regions Using Bayes Factor for Ordinal Group ResponsesFengjiao Dunbar, Hongyan Xu, Duchwan Ryu, et al.
American Journal of Hematology|December 28, 2020
Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myelomaJonathan L Kaufman, Cristina Gasparetto, Fredrik H Schjesvold, et al.
Pediatric Blood & Cancer|March 10, 2025
Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaAndrew E Place, Seth E Karol, Christopher J Forlenza, et al.
Pediatric Blood & Cancer|April 23, 2025
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid LeukaemiaSeth E Karol, Seong L Khaw, C Michel Zwaan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
BMC Bioinformatics|May 18, 2021
Estimating colocalization probability from limited summary statisticsEmily A King, Fengjiao Dunbar, Justin Wade Davis, et al.
Genes|September 20, 2019
Detection of Differentially Methylated Regions Using Bayes Factor for Ordinal Group ResponsesFengjiao Dunbar, Hongyan Xu, Duchwan Ryu, et al.
American Journal of Hematology|December 28, 2020
Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myelomaJonathan L Kaufman, Cristina Gasparetto, Fredrik H Schjesvold, et al.
Pediatric Blood & Cancer|March 10, 2025
Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaAndrew E Place, Seth E Karol, Christopher J Forlenza, et al.
Pediatric Blood & Cancer|April 23, 2025
Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid LeukaemiaSeth E Karol, Seong L Khaw, C Michel Zwaan, et al.
Pageof 1